• 1
    Neary D, Snowden JS, Gustafson L et al. Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 1998; 51: 15461554.
  • 2
    Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. JAMA 2005; 294: 19341943.
  • 3
    Iwasaki K, Satoh-Nakagawa T, Maruyama M et al. A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. J. Clin. Psychiatry 2005; 66: 248252.
  • 4
    Kimura T, Hayashida H, Furukawa H, Miyauchi D. Five cases of frontotemporal dementia with behavioral symptoms improved by Yokukansan. Psychogeriatrics 2009; 9: 3843.
  • 5
    Hirono N, Mori E, Ikejiri Y et al. Japanese version of the Neuropsychiatric Inventory: A scoring system for neuropsychiatric disturbances in dementia patients. Brain Nerve 1997; 49: 266271 (in Japanese).
  • 6
    Shigenobu K, Ikeda M, Fukuhara R et al. The stereotypy rating inventory for frontotemporal lobar degeneration. Psychiatry Res. 2002; 110: 175187.
  • 7
    Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The neuropsychiatric inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 23082314.
  • 8
    Kaufer DI, Cummings JL, Christine D. Effect of tacrine on behavioral symptoms in Alzheimer's disease: An open-label study. J. Geriatr. Psychiatry Neurol. 2008; 9: 16.
  • 9
    Shigenobu K, Ikeda M, Fukuhara R et al. Reducing the burden of care for Alzheimer's disease through the amelioration of ‘delusions of theft’ by drug therapy. Int. J. Geriatr. Psychiatry 2002; 17: 211217.
  • 10
    Francis PT, Holmes C, Webster MT, Stratmann GC, Procter AW, Bowen DM. Preliminary neurochemical findings in non-Alzheimer dementia due to lobar atrophy. Dementia 1993; 4: 172177.
  • 11
    Proctor AW, Qurne M, Francis PT. Neurochemical features of frontotemporal dementia. Dement. Geriatr. Cogn. Disord. 1999; 10 (Suppl. 1): 8084.
  • 12
    Sparks DL, Markesbery WR. Altered serotonergic and cholinergic synaptic markers in Pick's disease. Arch. Neurol. 1991; 48: 796799.
  • 13
    Ishibashi A, Egashira N, Mishima K, Iwasaki K, Fujiwara M. Study on the central action of Yoku-kan-san. Yakugaku Zasshi 2006; 126 (Suppl. 2): 8284 (in Japanese).
  • 14
    Takeda A, Itoh H, Tamano H, Yuzuriha M, Oku N. Suppressive effect of Yokukansan on excessive release of glutamate and aspartate in the hippocampus of zinc-deficient rats. Nutr. Neurosci. 2008; 11: 4146.